A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
Study sponsor: Iovance Biotherapeutics, Inc. · IOVA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2028-05Estimated
Enrollment · participants60Estimated
Source updated2025-10-30Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.